Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbitocin in Reduction of Blood Loss During Myomectomy
NCT07721623Phase 1Not yet recruiting
- Sponsor
- Alex Ekwueme Federal University Teaching Hospital
- Start
- Aug 2026
- Primary completion
- Aug 2028
01
Overview
Phase 1, randomised, double-blind trial of carbetocin (2 arms), sponsored by Alex Ekwueme Federal University Teaching Hospital. Primary endpoint: Haemoglobin Change at 24 months. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
carbetocin
Beyond the preview
Go deeper on NCT07721623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07721623.